1. Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies Guidance for Industry;US Department of Health and Human Services,2019
2. FDA Reauthorization Act of 2017, 21 U.S. Code § 301,2017
3. Evaluating Inclusion and Exclusion Criteria in Clinical Trials; Public Meeting. Fed Regist. 83 FR 4210,2018
4. Enhancing the Diversity of Clinical Trial Populations – Eligibility Criteria, Enrollment Practices, and Trial Designs; Guidance for Industry;US Department of Health and Human Services,2020
5. 2020 Drug Trials Snapshots Summary Report;US Food and Drug Administration,2021